Large molecules, larger data
The theoretical molecular space for large molecules is nearly infinite. On the plus side, this gives you a lot of room to maneuver when designing therapeutic Peptides, oligonucleotides, and antibodies. On the down side, it is difficult to use existing information to guide your structural biology programs while ensuring patentability of the engineered molecules.
GOSTAR™ Large Molecules enables you to thread that needle.
By providing you with exactly the data you need on your area of interest in the large molecule landscape, we empower you to make confident biologic development decisions, fuel your algorithms, and avoid costly later-stage pitfalls.

The data you need. The data quality you require.
GOSTAR™ Large Molecules is a fully custom curated database, so you get exactly the data you need. Imagine a database where every data point is relevant to your research. That’s what GOSTAR™ Large Molecules delivers.
With GOSTAR™ Large Molecules, we have improved our industry-best QC procedures even further. The fully manually curated data undergoes a three stage QMS-ISO-9001:2015 certified quality control process, ensuring unsurpassed data accuracy.
What GOSTAR™ Large Molecules covers
What GOSTAR™ Large Molecules covers
Antibodies
Oligonucleotides
Peptides
The power of GOSTAR™ curation
As many as
24
As little as
48
Industry-leading
3
As many as
24
As little as
48
Industry-leading
3
Get the most relevant large molecule data set – Try GOSTAR™ Large Molecules today!

Case study
Unveiling the molecular code: Antibody sequence mining and target affinity analysis
The client is an artificial intelligence (AI) drug discovery company bringing a magical revolution to the drug discovery journey. We helped them leverage antibody sequence and target affinity data, which was structured and annotated meticulously. This empowerment facilitated the creation of robust training datasets. These datasets serve as the bedrock for training AI and advanced machine learning algorithms, enabling the achievement of precision in personalized medicine.
Upon analyzing antibody affinity data, the client identified antibodies that exhibit polypharmacology beyond their primary pharmacology. This knowledge enabled the client to explore the repurposing of approved antibodies, leveraging their characteristics and expanding their therapeutic potential to address unmet medical needs.
Knowledge hub
Filter
Frequently asked questions
How long will it take to receive the data I have requested?
How will I receive my data?
Custom curation sounds expensive. How much does GOSTAR™ Large Molecules cost?
Will I receive updates after I receive my initial data?
Get the large molecule data you need
Try GOSTAR™ Large Molecules. We’re certain that when you experience the most rich, relevant, highly accurate data, you’ll develop an unequaled avidity for it.
"*" indicates required fields